X-Vax Technology

Biotechnology company developing a vaccine to prevent and treat herpes simplex virus (HSV) infections, addressing a significant unmet medical need affecting billions of people worldwide.

Location
New York, New York, USA
Founded
2015
Investors
1
Categories
vaccines, infectious-disease, biotech, herpes

Investors

NameLocationTypeStagesPortfolio
Adjuvant CapitalWashington, DC, USAbiotech-focused
seedseries-a+3
16